myoma

(redirected from uterine myoma)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to uterine myoma: ovarian cyst, nabothian cyst, adenomyosis

my·o·ma

 (mī-ō′mə)
n. pl. my·o·mas or my·o·ma·ta (-mə-tə)
A tumor composed of muscle tissue.

my·o′ma·tous (-ō′mə-təs, -ŏm′ə-) adj.

myoma

(maɪˈəʊmə)
n, pl -mas or -mata (-mətə)
(Pathology) a benign tumour composed of muscle tissue
myˈomatous adj

my•o•ma

(maɪˈoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor composed of muscle tissue.
[1870–75]
my•om′a•tous (-ˈɒm ə təs, -ˈoʊ mə-) adj.

myoma

A benign tumor of muscle.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.myoma - a benign tumor composed of muscle tissue
leiomyoma - benign tumor of smooth muscle (usually in the uterus or digestive tract)
rhabdomyoma - benign rumor of striated muscle
Translations

my·o·ma

n. mioma, tumor benigno compuesto de tejido muscular.
___ previum___ previo.

myoma

n mioma m; uterine — mioma uterino
References in periodicals archive ?
He is internationally recognized for his pioneering work in developing minimally invasive surgical techniques and establishing evidence-based protocols for management and treatment of different pelvic disorders such as endometriosis, ovarian cysts and uterine myoma.
PregLem's lead product, PGL4001 Esmya(TM), completed Phase III clinical trials in June 2010 for the treatment of uterine myoma.
After review, the differential diagnosis was finally proposed as follows: primary ovarian lesion, pedunculated uterine myoma with sarcomatous degeneration and an ovarian metastasis.
Effects of hormone replacement therapy on postmenopausal uterine myoma.
Effects of levonorgestrel-releasing intrauterine system on the endometrium and the relevance to the management of menorrhagia caused by uterine myoma and adenomyosis," in T.
PregLem's lead product, PGL4001 (Esmya[TM]), successfully completed Phase III clinical trials in June 2010 for the treatment of uterine myoma.
Ovarian fibroma is often difficult to diagnose preoperatively and usually misdiagnosed as uterine myoma, because of the solid nature of the mass on examination, and the ultrasonic similarities between the two anomalies.
Cetrorelix has successfully completed a broad 7-Phase 2 program in BPH, endometriosis, and uterine myoma.